Central Laboratories Featured Articles

  1. CTTC Opens With A Reality Check On AI 7/7/2026

    I expected the Clinical Trials Technology Congress opening plenary to focus on AI's latest capabilities. Instead, speakers challenged attendees to think about the harder work that comes first: connecting data, redesigning workflows, and helping people embrace new ways of working. It was a refreshing reality check on what AI adoption really requires.

  2. i-Cubed Used End-To-End AI In A Proof-Of-Concept Trial. Here's What They Learned 7/2/2026

    Discover how well AI fared in document generation, patient engagement, data integration, and more in an end-to-end proof-of-concept study run by i-Cubed.

  3. Understanding And Preserving Data Flow Integrity In AI-Assisted Clinical Trials 6/26/2026

    Learn from ex-FDA and ELIQUENT consultant Dawn Wydner, Ph.D.., how treating data integrity as an end-to-end clinical information flow issue, rather than a database-only concern, is essential to managing AI-related risk.

  4. Where Are We With Clinical Trial Tokenization? 6/19/2026

    In January 2024, I interviewed Tom Dougherty about a topic many clinical research professionals had heard mentioned but few could confidently explain: tokenization. I wanted to get caught up on any progress that has been made, so I completed this Q&A with Dougherty, who is Real-World Data Strategy Director, CMR - Clinical Data Science & Evidence at Novo Nordisk.

  5. The Compliance Problem With Excel Trackers And Other Computational Tools — And How AI Can Help 6/16/2026

    Everyday computational tools such as Excel are simple and easy to use, but they carry risk. Learn how these tools might not adhere to 21 CFR Part 11, and discover how AI can help keep them compliant.

  6. It's A Fact: Sharing Clinical Trial Results With Participants Builds Trust 5/14/2026

    CISCRP experts share results from their annual Perceptions & Insights Study showing that patients continue to place a high value on receiving both individual and overall study results.

  7. Reimagining Data Governance For The AI Era 4/24/2026

    Understand the persistent governance challenges that undermine AI initiatives and walk away with a robust blueprint for building a resilient, scalable, and ethically sound framework.

  8. Is It Time To Replace RECIST — Or Just Add AI? 4/16/2026

    Immunocore Chief Regulatory and Quality Officer Mark Moyer explains why new tools, including AI-based approaches, may better capture cancer treatment response than existing measures, such as ir-RECIST.

  9. RBQM And Centralized Monitoring Need Action 4/10/2026

    After COVID forced sponsors to move faster than ever, many are now confronting a harder challenge: ownership. Marci Thear explains why RBQM and centralized monitoring only work when sponsors move beyond reviewing outputs and start acting on the signals.

  10. Redefining Patient Outcomes Measurement Using RWE Data 4/7/2026

    Discover an outcome-channeling framework that organizes patient outcomes into multidimensional domains, emphasizing longitudinal trajectories rather than single time endpoints.